Aripiprazole, a novel antipsychotic drug, inhibits quinpriole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum
- 1 February 1997
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 321 (1), 105-111
- https://doi.org/10.1016/s0014-2999(96)00920-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brainNeuropharmacology, 1995
- Supersensitivity of quinpirole-evoked GTPase activation without changes in gene expression of D2 and Gi protein in the striatum of hemi-dopaminergic lesioned ratsNeuroscience Letters, 1994
- Both splicing variants of the dopamine D2 receptor mRNA are up-regulated by antipsychotic drugsNeuroscience Letters, 1993
- Molecular biology of dopamine receptorsTrends in Pharmacological Sciences, 1992
- Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatmentEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Functional Reconstitution of Purified Giand Gowith ?-Opioid Receptors in Guinea Pig Striatal Membranes Pretreated with Micromolar Concentrations of N-EthylmaleimideJournal of Neurochemistry, 1990
- Multiple D2 dopamine receptors produced by alternative RNA splicingNature, 1989
- Alternative splicing directs the expression of two D2 dopamine receptor isoformsNature, 1989
- Cloning and expression of a rat D2 dopamine receptor cDNANature, 1988
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976